Matches in Wikidata for { <http://www.wikidata.org/entity/Q98625277> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q98625277 description "article scientifique publié en 2020" @default.
- Q98625277 description "artículu científicu espublizáu n'agostu de 2020" @default.
- Q98625277 description "scientific article published on 22 August 2020" @default.
- Q98625277 description "wetenschappelijk artikel" @default.
- Q98625277 description "наукова стаття, опублікована 22 серпня 2020" @default.
- Q98625277 name "Treatment patterns and costs among patients with OAB treated with combination oral therapy, sacral nerve stimulation, percutaneous tibial nerve stimulation, or onabotulinumtoxinA in the United States" @default.
- Q98625277 name "Treatment patterns and costs among patients with OAB treated with combination oral therapy, sacral nerve stimulation, percutaneous tibial nerve stimulation, or onabotulinumtoxinA in the United States" @default.
- Q98625277 type Item @default.
- Q98625277 label "Treatment patterns and costs among patients with OAB treated with combination oral therapy, sacral nerve stimulation, percutaneous tibial nerve stimulation, or onabotulinumtoxinA in the United States" @default.
- Q98625277 label "Treatment patterns and costs among patients with OAB treated with combination oral therapy, sacral nerve stimulation, percutaneous tibial nerve stimulation, or onabotulinumtoxinA in the United States" @default.
- Q98625277 prefLabel "Treatment patterns and costs among patients with OAB treated with combination oral therapy, sacral nerve stimulation, percutaneous tibial nerve stimulation, or onabotulinumtoxinA in the United States" @default.
- Q98625277 prefLabel "Treatment patterns and costs among patients with OAB treated with combination oral therapy, sacral nerve stimulation, percutaneous tibial nerve stimulation, or onabotulinumtoxinA in the United States" @default.
- Q98625277 P1433 Q98625277-2E95BFE6-14CD-496D-8F9A-BD0908B2FA54 @default.
- Q98625277 P1476 Q98625277-2D3D769B-9A5B-4F43-9E88-BBD9B6BFC9E4 @default.
- Q98625277 P2093 Q98625277-31627917-9678-45BA-916E-96A52F391694 @default.
- Q98625277 P2093 Q98625277-32E300AC-48D9-47A5-941D-842A9304D090 @default.
- Q98625277 P2093 Q98625277-60316166-A2B1-4FCA-A139-102DA8216C5F @default.
- Q98625277 P2093 Q98625277-B7918C45-D7A0-4DBD-890E-84D742631B9E @default.
- Q98625277 P31 Q98625277-53C557BE-4A8B-4D10-9988-A20DA3A0F23E @default.
- Q98625277 P356 Q98625277-2C4FD7B2-A6AB-40B9-878E-4C59C9A33802 @default.
- Q98625277 P50 Q98625277-A7C1690D-AC3E-4894-A58F-87A43662CA44 @default.
- Q98625277 P50 Q98625277-C7982F57-ECD9-4E50-A4BF-9E831D483493 @default.
- Q98625277 P577 Q98625277-1F54B1AE-95CB-4D13-9063-8C9A1A08FF72 @default.
- Q98625277 P698 Q98625277-D298705C-5FAC-4760-8163-A191441C0C78 @default.
- Q98625277 P921 Q98625277-9234F93C-1C85-40DC-9BC1-7BFB3CE239B2 @default.
- Q98625277 P932 Q98625277-58DDD8ED-4293-4A3F-8D23-34E538A24B20 @default.
- Q98625277 P356 NAU.24474 @default.
- Q98625277 P698 32827230 @default.
- Q98625277 P1433 Q15753354 @default.
- Q98625277 P1476 "Treatment patterns and costs among patients with OAB treated with combination oral therapy, sacral nerve stimulation, percutaneous tibial nerve stimulation, or onabotulinumtoxinA in the United States" @default.
- Q98625277 P2093 "Basia Rogula" @default.
- Q98625277 P2093 "Christina Qian" @default.
- Q98625277 P2093 "Shelagh M Szabo" @default.
- Q98625277 P2093 "Stephen R Kraus" @default.
- Q98625277 P31 Q13442814 @default.
- Q98625277 P356 "10.1002/NAU.24474" @default.
- Q98625277 P50 Q46329307 @default.
- Q98625277 P50 Q94560215 @default.
- Q98625277 P577 "2020-08-22T00:00:00Z" @default.
- Q98625277 P698 "32827230" @default.
- Q98625277 P921 Q4095199 @default.
- Q98625277 P932 "7693053" @default.